Skip to content
10-K

Annual Report

CymaBay Therapeutics, Inc.

0001193125-24-050758

← back to feed
Filed
Feb 28, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jan 31, 2024 114.72M sh
Shares Diluted FY 2023 · Dec 31, 2023 106.2M sh
Shares Diluted FY 2023 · Dec 31, 2022 87.8M sh
Shares Diluted FY 2023 · Dec 31, 2021 71.06M sh
Capex FY 2023 · Dec 31, 2023 $445K
Capex FY 2023 · Dec 31, 2022 $148K
Capex FY 2023 · Dec 31, 2021 $87K
Operating Cash Flow FY 2023 · Dec 31, 2023 −$72.53M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$84.08M
Operating Cash Flow FY 2023 · Dec 31, 2021 −$69.43M
Cash And Equivalents FY 2023 · Dec 31, 2023 $206.54M
Cash And Equivalents FY 2023 · Dec 31, 2022 $20.29M
Stockholders Equity FY 2023 · Dec 31, 2023 $292.26M
Stockholders Equity FY 2023 · Dec 31, 2022 $36.15M
Stockholders Equity FY 2023 · Dec 31, 2021 $132.94M
Stockholders Equity FY 2023 · Dec 31, 2020 $142.71M
Current Liabilities FY 2023 · Dec 31, 2023 $36.84M
Current Liabilities FY 2023 · Dec 31, 2022 $15.44M
Total Liabilities FY 2023 · Dec 31, 2023 $142.43M
Total Liabilities FY 2023 · Dec 31, 2022 $105.7M
Current Assets FY 2023 · Dec 31, 2023 $403.8M
Current Assets FY 2023 · Dec 31, 2022 $138.07M
Total Assets FY 2023 · Dec 31, 2023 $434.69M
Total Assets FY 2023 · Dec 31, 2022 $141.85M
Eps Diluted FY 2023 · Dec 31, 2023 −$0.99
Eps Diluted FY 2023 · Dec 31, 2022 −$1.21
Eps Diluted FY 2023 · Dec 31, 2021 −$1.27
Eps Basic FY 2023 · Dec 31, 2023 −$0.99
Eps Basic FY 2023 · Dec 31, 2022 −$1.21
Eps Basic FY 2023 · Dec 31, 2021 −$1.27
Sga Expense FY 2023 · Dec 31, 2023 $51.95M
Sga Expense FY 2023 · Dec 31, 2022 $25.12M
Sga Expense FY 2023 · Dec 31, 2021 $23.04M
Rd Expense FY 2023 · Dec 31, 2023 $80.8M
Rd Expense FY 2023 · Dec 31, 2022 $68M
Rd Expense FY 2023 · Dec 31, 2021 $64.54M
Net Income FY 2023 · Dec 31, 2023 −$105.37M
Net Income FY 2023 · Dec 31, 2022 −$106M
Net Income FY 2023 · Dec 31, 2021 −$90M
Operating Income FY 2023 · Dec 31, 2023 −$101.68M
Operating Income FY 2023 · Dec 31, 2022 −$93.11M
Operating Income FY 2023 · Dec 31, 2021 −$87.58M
Stock Issued FY 2023 · Sep 11, 2023 14.52M sh
Stock Issued FY 2023 · Jan 23, 2023 11.82M sh